📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
40
Warrant Exposure
40
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
38%
🔄 Reverse Split
55%
• 50-day avg $0.08 below $1 exchange minimum
📜 Warrant Exercise
35%
• Massive warrant overhang: 311156000% of shares outstanding
💹 Market Data
Market CapN/A
Shares OutstandingN/A
Float12.98M
Cash$173.6K
Debt$980.8K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest11.4K
Days to Cover6.2
% of Float0.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Sep 30, 2018
xbrl
XBRL WARRANT
Apr 20, 2018
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for VYCO
📊 VYCO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 VYCO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.